Cargando…

Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents

A novel bromide salt of the antidepressant bupropion (bupropion HBr) has recently been developed and approved for use in the United States. Given previous use of bromides to treat seizures, and that the existing chloride salt of bupropion (HCl) can cause seizures, it is important to determine if the...

Descripción completa

Detalles Bibliográficos
Autores principales: Henshall, David C, Dürmüller, Nick, White, H Steve, Williams, Robert, Moser, Paul, Dunleavy, Mark, Silverstone, Peter H
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695230/
https://www.ncbi.nlm.nih.gov/pubmed/19557114
_version_ 1782168173715390464
author Henshall, David C
Dürmüller, Nick
White, H Steve
Williams, Robert
Moser, Paul
Dunleavy, Mark
Silverstone, Peter H
author_facet Henshall, David C
Dürmüller, Nick
White, H Steve
Williams, Robert
Moser, Paul
Dunleavy, Mark
Silverstone, Peter H
author_sort Henshall, David C
collection PubMed
description A novel bromide salt of the antidepressant bupropion (bupropion HBr) has recently been developed and approved for use in the United States. Given previous use of bromides to treat seizures, and that the existing chloride salt of bupropion (HCl) can cause seizures, it is important to determine if the HBr salt may be less likely to cause seizures than the HCl salt. In the present animal studies this was evaluated by means of quantified electroencephalogram (EEG), observation, and the rotarod test in mice and rats. Both bupropion salts were tested at increasing equimolar doses administered intraperitoneally. The results in mice showed that bupropion HCl 125 mg/kg induced a significantly higher ten-fold increase in the mean number of cortical EEG seizures compared to bupropion HBr (7.50 ± 2.56 vs 0.75 ± 0.96; p = 0.045), but neither drug caused any brain injuries. In rats bupropion HBr 100 mg/kg induced single EEG seizure activity in the cortical and hippocampal (depth) electrodes and in significantly (p < 0.05) fewer rats (44%) compared to bupropion HCl, which induced 1 to 4 convulsions per rat in all rats (100%) dosed. The total duration of cortical seizures in bupropion HCl-treated rats was significantly longer than the corresponding values obtained in bupropion HBr-treated rats (424.6 seconds vs 124.5 seconds respectively, p < 0.05). Bupropion HCl consistently induced more severe convulsions at each dose level compared to bupropion HBr. Both treatments demonstrated a similar dose-dependent impairment of rotarod performance in mice. In conclusion, these findings suggest that bupropion HBr may have a significantly lower potential to induce seizures in mice and rats, particularly at higher doses, compared to bupropion HCl. Determination of this potential clinical advantage will require human studies. If confirmed by such studies, it is likely that this potential beneficial clinical benefit would be due to the presence of the bromide salt given the long history of the use of bromide to treat seizure disorders.
format Text
id pubmed-2695230
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26952302009-06-16 Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents Henshall, David C Dürmüller, Nick White, H Steve Williams, Robert Moser, Paul Dunleavy, Mark Silverstone, Peter H Neuropsychiatr Dis Treat Original Research A novel bromide salt of the antidepressant bupropion (bupropion HBr) has recently been developed and approved for use in the United States. Given previous use of bromides to treat seizures, and that the existing chloride salt of bupropion (HCl) can cause seizures, it is important to determine if the HBr salt may be less likely to cause seizures than the HCl salt. In the present animal studies this was evaluated by means of quantified electroencephalogram (EEG), observation, and the rotarod test in mice and rats. Both bupropion salts were tested at increasing equimolar doses administered intraperitoneally. The results in mice showed that bupropion HCl 125 mg/kg induced a significantly higher ten-fold increase in the mean number of cortical EEG seizures compared to bupropion HBr (7.50 ± 2.56 vs 0.75 ± 0.96; p = 0.045), but neither drug caused any brain injuries. In rats bupropion HBr 100 mg/kg induced single EEG seizure activity in the cortical and hippocampal (depth) electrodes and in significantly (p < 0.05) fewer rats (44%) compared to bupropion HCl, which induced 1 to 4 convulsions per rat in all rats (100%) dosed. The total duration of cortical seizures in bupropion HCl-treated rats was significantly longer than the corresponding values obtained in bupropion HBr-treated rats (424.6 seconds vs 124.5 seconds respectively, p < 0.05). Bupropion HCl consistently induced more severe convulsions at each dose level compared to bupropion HBr. Both treatments demonstrated a similar dose-dependent impairment of rotarod performance in mice. In conclusion, these findings suggest that bupropion HBr may have a significantly lower potential to induce seizures in mice and rats, particularly at higher doses, compared to bupropion HCl. Determination of this potential clinical advantage will require human studies. If confirmed by such studies, it is likely that this potential beneficial clinical benefit would be due to the presence of the bromide salt given the long history of the use of bromide to treat seizure disorders. Dove Medical Press 2009 2009-04-08 /pmc/articles/PMC2695230/ /pubmed/19557114 Text en © 2009 Henshall et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Henshall, David C
Dürmüller, Nick
White, H Steve
Williams, Robert
Moser, Paul
Dunleavy, Mark
Silverstone, Peter H
Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents
title Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents
title_full Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents
title_fullStr Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents
title_full_unstemmed Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents
title_short Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents
title_sort electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695230/
https://www.ncbi.nlm.nih.gov/pubmed/19557114
work_keys_str_mv AT henshalldavidc electroencephalographicandbehavioralconvulsanteffectsofhydrobromideandhydrochloridesaltsofbupropioninconsciousrodents
AT durmullernick electroencephalographicandbehavioralconvulsanteffectsofhydrobromideandhydrochloridesaltsofbupropioninconsciousrodents
AT whitehsteve electroencephalographicandbehavioralconvulsanteffectsofhydrobromideandhydrochloridesaltsofbupropioninconsciousrodents
AT williamsrobert electroencephalographicandbehavioralconvulsanteffectsofhydrobromideandhydrochloridesaltsofbupropioninconsciousrodents
AT moserpaul electroencephalographicandbehavioralconvulsanteffectsofhydrobromideandhydrochloridesaltsofbupropioninconsciousrodents
AT dunleavymark electroencephalographicandbehavioralconvulsanteffectsofhydrobromideandhydrochloridesaltsofbupropioninconsciousrodents
AT silverstonepeterh electroencephalographicandbehavioralconvulsanteffectsofhydrobromideandhydrochloridesaltsofbupropioninconsciousrodents